Entity/Public Space Stock Epinephrine

Stock epinephrine is rapidly moving beyond the school walls and out to public venues – from theme parks, restaurants and sports arenas to daycare centers and more.

Thirty-one states have now passed what are called “entity laws” (as of March 1, 2018), legislation that permits venues to maintain an epinephrine auto-injector, with the intention of reducing the time it takes to get lifesaving epinephrine to a person having a sudden anaphylactic reaction.

States colored red are without entity legislation.

Click on the state listings below to read the legislation.

 

 Green states:  Red states:
Alaska Connecticut
Alabama Delaware
Arkansas District of Columbia
Arizona Illinois
California Hawaii
Colorado Kansas
Florida Louisiana
Georgia Maryland
Idaho Massachusetts
Indiana Mississippi
Iowa Montana
Kentucky Nebraska
Michigan New Mexico
Minnesota North Dakota
Missouri Pennsylvania
Maine  South Dakota
Nevada  Texas
New Hampshire  Vermont
New Jersey  Virginia
New York  Wyoming
North Carolina
Ohio
Oklahoma
Oregon
Rhode Island
South Carolina
Tennessee
Utah
Washington
West Virginia
Wisconsin

For questions and to get involved in Entity Legislation in your state, contact Charmayne Anderson at canderson@allergyasthmanetwork.org or 800.878.4403.